Medicare Enrolled
Dr. Olusegun Oseni, MD, FCCP
Internal Medicine · Weatherford, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Oseni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oseni?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oseni
Dr. Olusegun Oseni is an internal medicine specialist in Weatherford, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Oseni performed 16,524 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Oseni received a total of $15,615 from 51 pharmaceutical and/or device companies across 941 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oseni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 2% volume in TX
$15,615 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗16,524
Medicare services
Top 2% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Omalizumab injection (Xolair) for asthma/allergy | 4,475 | $30 | $113 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,325 | $90 | $305 |
| Injection, benralizumab, 1 mg | 2,010 | $133 | $505 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
903 | $28 | $178 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
900 | $41 | $173 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
851 | $40 | $169 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
800 | $132 | $408 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
708 | $46 | $76 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
473 | $19 | $104 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
399 | $53 | $245 |
| New patient office visit, complex (60-74 min) | 375 | $162 | $583 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
331 | $25 | $109 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
326 | $12 | $51 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
320 | $10 | $72 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
281 | $18 | $69 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
184 | $0 | $25 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
148 | $476 | $1,859 |
| Exercise stress test A test that monitors the heart and lungs while the patient exercises to evaluate their function under physical stress. |
146 | $112 | $470 |
| Home sleep study test with type II portable monitor An unattended sleep study performed at home using a portable monitor that records at least seven channels, including brain activity, eye movement, muscle activity, heart rate, airflow, breathing effort, and oxygen levels. |
126 | $110 | $478 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
83 | $457 | $1,787 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
83 | $4 | $30 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
79 | $14 | $40 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
78 | $36 | $150 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
58 | $41 | $369 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
29 | $7 | $53 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
21 | $332 | $1,257 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
12 | $58 | $398 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,615
Total received (2018-2024)
Avg $2,231/year across 7 years
Top 6% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
941
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,292
2023
$2,030
2022
$1,996
2021
$1,558
2020
$1,909
2019
$3,041
2018
$3,790
Payments by company (2024)
GENZYME CORPORATION
$293
Inspire Medical Systems, Inc.
$225
AstraZeneca Pharmaceuticals LP
$200
Baxter Healthcare
$186
Regeneron Healthcare Solutions, Inc.
$81
GlaxoSmithKline, LLC.
$75
Grifols USA, LLC
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Genentech USA, Inc.
$35
Insmed, Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$21
JAZZ PHARMACEUTICALS INC.
$17
Hikma Pharmaceuticals USA
$13
INOGEN, INC.
$7
Top 3 companies account for 55.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,726
AstraZeneca Pharmaceuticals LP
$2,579
GENZYME CORPORATION
$1,381
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,229
Grifols USA, LLC
$974
Mylan Specialty L.P.
$731
Regeneron Healthcare Solutions, Inc.
$715
Inspire Medical Systems, Inc.
$612
Sunovion Pharmaceuticals Inc.
$517
Genentech USA, Inc.
$475
Takeda Pharmaceuticals U.S.A., Inc.
$276
Jazz Pharmaceuticals Inc.
$269
Baxter Healthcare
$254
JAZZ PHARMACEUTICALS INC.
$250
Electromed, Inc.
$242
Actelion Pharmaceuticals US, Inc.
$231
United Therapeutics Corporation
$221
Philips Electronics North America Corporation
$207
Novartis Pharmaceuticals Corporation
$184
ADVANCED RESPIRATORY, INC
$151
Eisai Inc.
$138
Pulmonx Corporation
$135
Insmed, Inc.
$124
Advanced Respiratory, Inc
$121
Shire North American Group Inc
$88
Circassia Pharmaceuticals Inc
$72
Fisher & Paykel Healthcare Inc
$60
PFIZER INC.
$56
Mallinckrodt Hospital Products Inc.
$56
Harmony Biosciences LLC
$55
OptiNose US, Inc.
$47
Mallinckrodt Enterprises LLC
$47
Genentech, Inc.
$40
Amgen Inc.
$40
Teva Pharmaceuticals USA, Inc.
$40
Veran Medical Technologies, Inc.
$28
ARBOR PHARMACEUTICALS, INC.
$25
Merck Sharp & Dohme Corporation
$25
Exeltis, USA Inc.
$22
Novo Nordisk Inc
$18
UCB, Inc.
$18
Optinose US, Inc.
$17
Inogen, Inc.
$16
Janssen Pharmaceuticals, Inc
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Mallinckrodt LLC
$14
Hikma Pharmaceuticals USA
$13
Covis Pharma GmBH
$13
SANOFI-AVENTIS U.S. LLC
$13
HARMONY BIOSCIENCES LLC
$12
INOGEN, INC.
$7
Top 3 companies account for 42.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BROVANA · CHANTIX · CHARTIS CATHETER · CUTAQUIG · CUVITRU · DUPIXENT · Dayvigo · Dymista · ELIQUIS · Epinephrine · Esbriet · FARXIGA · FASENRA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · Horizant · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · Neupro · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · QVAR · Respiratoriy Care Undiv · Ryaltris · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · Sleep Other · Spin · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Trilogy 100 · Utibron · Vitrakvi · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
147
County median income
$102,099
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY WEATHERFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Oseni is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Oseni experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Oseni performed 4,475 omalizumab injection (xolair) for asthma/allergy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Oseni receive payments from pharmaceutical companies?
Yes. Dr. Oseni received a total of $15,615 from 51 companies across 941 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oseni's costs compare to other internal medicine physicians in Weatherford?
Dr. Oseni's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oseni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Weatherford
Browse internal medicine physicians in Weatherford ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology